ARS Pharmaceuticals, Inc. revenue for the last year amounted to 30.00 k USD, the most of which — 30.00 k USD — came from its highest performing source at the moment, Needle-free Intranasal, the year earlier bringing 1.32 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought ARS Pharmaceuticals, Inc. 30.00 k USD, and the year before that — 1.32 M USD.